Home Tags Metastatic Breast Cancer

Tag: Metastatic Breast Cancer

FDA Approves Camizestrant Despite Negative ODAC Vote: What It Means for...

Peter Hofland -
Featured image: Encouraging mother with breast cancer. 2018-2020 Fotolia/Adobe. used with permission.

ASCO 2025: Elacestrant Demonstrates Potential Role as an Endocrine Therapy Backbone...

Danielle Garcia -

Treatment Guided by CTC Count May Improve Long-term Outcomes in Patients...

Editorial Team -

FDA Accepts Byondis’ BLA for [Vic-] Trastuzumab Duocarmazine in HER2+ mBC

Editorial Team -

Ribociclib Trial Data Shows Longest Median OS Ever Reported in HR+/HER2-...

Editorial Team -

SABCS 2020: Circulating Tumor Cell may Predict Treatment Response and Prognosis...

Editorial Team -
Ian E Krop, MD, Ph.D, Associate chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, speaks during the General Session on Wednesday, December 11, 2019. during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. Photo coutesy © 2019 AACR/SABCS Todd Buchanan.

SABCS 2019: Trastuzumab Deruxtecan Achieves Clinically Meaningful and Durable Response

Peter Hofland -

Phase II Trial Evaluating Lurbinectedin Shows Notable Efficacy in BRCA 1...

Danielle Garcia -

Abemaciclib Approved for the Treatment of Advanced or Metastatic Breast...

Peter Hofland -

Metastatic Breast Cancer Patients With Elevated Circulating Tumor Cells(CTCs) do not...

Editorial Team -

LATEST NEWS